Cargando…
Topography of Simulated Intestinal Equilibrium Solubility
[Image: see text] Oral administration of a solid dosage form requires drug dissolution in the gastrointestinal tract before absorption. Solubility is a key factor controlling dissolution, and it is recognized that, within the intestinal tract, this is influenced by the luminal fluid pH, amphiphile c...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505523/ https://www.ncbi.nlm.nih.gov/pubmed/30848917 http://dx.doi.org/10.1021/acs.molpharmaceut.8b01238 |
_version_ | 1783416773705465856 |
---|---|
author | Dunn, Claire Perrier, Jeremy Khadra, Ibrahim Wilson, Clive G. Halbert, Gavin W. |
author_facet | Dunn, Claire Perrier, Jeremy Khadra, Ibrahim Wilson, Clive G. Halbert, Gavin W. |
author_sort | Dunn, Claire |
collection | PubMed |
description | [Image: see text] Oral administration of a solid dosage form requires drug dissolution in the gastrointestinal tract before absorption. Solubility is a key factor controlling dissolution, and it is recognized that, within the intestinal tract, this is influenced by the luminal fluid pH, amphiphile content, and composition. Various simulated intestinal fluid recipes have been introduced to mimic this behavior and studied using a range of different experimental techniques. In this article, we have measured equilibrium solubility utilizing a novel four component mixture design (4CMD) with biorelevant amphiphiles (bile salt, phospholipid, oleate, and monoglyceride) within a matrix of three pH values (5, 6, and 7) and total amphiphile concentrations (11.7, 30.6, and 77.5 mM) to provide a topographical and statistical overview. Three poorly soluble drugs representing acidic (indomethacin), basic (carvedilol), and neutral (fenofibrate) categories have been studied. The macroscopic solubility behavior agrees with literature and exhibits an overall increasing solubility from low pH and total amphiphile concentration to high pH and total amphiphile concentration. Within the matrix, all three drugs display different topographies, which can be related to the statistical effect levels of the individual amphiphiles or amphiphile interactions on solubility. The study also identifies previously unreported three and four way factor interactions notably between bile salt, phospholipid, pH, and total amphiphile concentration. In addition, the results also reveal that solubility variability is linked to the number of amphiphiles and the respective ratios in the measurement fluid, with the minimum variation present in systems containing all four amphiphiles. The individual 4CMD experiments within the matrix can be linked to provide a possible intestinal solubility window for each drug that could be applied in PBPK modeling systems. Overall the approach provides a novel overview of intestinal solubility topography along with greater detail on the impact of the various factors studied; however, each matrix requires 351 individual solubility measurements. Further studies will be required to refine the experimental protocol in order the maximize information garnered while minimizing the number of measurements required. |
format | Online Article Text |
id | pubmed-6505523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | American Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-65055232019-05-23 Topography of Simulated Intestinal Equilibrium Solubility Dunn, Claire Perrier, Jeremy Khadra, Ibrahim Wilson, Clive G. Halbert, Gavin W. Mol Pharm [Image: see text] Oral administration of a solid dosage form requires drug dissolution in the gastrointestinal tract before absorption. Solubility is a key factor controlling dissolution, and it is recognized that, within the intestinal tract, this is influenced by the luminal fluid pH, amphiphile content, and composition. Various simulated intestinal fluid recipes have been introduced to mimic this behavior and studied using a range of different experimental techniques. In this article, we have measured equilibrium solubility utilizing a novel four component mixture design (4CMD) with biorelevant amphiphiles (bile salt, phospholipid, oleate, and monoglyceride) within a matrix of three pH values (5, 6, and 7) and total amphiphile concentrations (11.7, 30.6, and 77.5 mM) to provide a topographical and statistical overview. Three poorly soluble drugs representing acidic (indomethacin), basic (carvedilol), and neutral (fenofibrate) categories have been studied. The macroscopic solubility behavior agrees with literature and exhibits an overall increasing solubility from low pH and total amphiphile concentration to high pH and total amphiphile concentration. Within the matrix, all three drugs display different topographies, which can be related to the statistical effect levels of the individual amphiphiles or amphiphile interactions on solubility. The study also identifies previously unreported three and four way factor interactions notably between bile salt, phospholipid, pH, and total amphiphile concentration. In addition, the results also reveal that solubility variability is linked to the number of amphiphiles and the respective ratios in the measurement fluid, with the minimum variation present in systems containing all four amphiphiles. The individual 4CMD experiments within the matrix can be linked to provide a possible intestinal solubility window for each drug that could be applied in PBPK modeling systems. Overall the approach provides a novel overview of intestinal solubility topography along with greater detail on the impact of the various factors studied; however, each matrix requires 351 individual solubility measurements. Further studies will be required to refine the experimental protocol in order the maximize information garnered while minimizing the number of measurements required. American Chemical Society 2019-03-08 2019-05-06 /pmc/articles/PMC6505523/ /pubmed/30848917 http://dx.doi.org/10.1021/acs.molpharmaceut.8b01238 Text en Copyright © 2019 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited. |
spellingShingle | Dunn, Claire Perrier, Jeremy Khadra, Ibrahim Wilson, Clive G. Halbert, Gavin W. Topography of Simulated Intestinal Equilibrium Solubility |
title | Topography of Simulated Intestinal Equilibrium Solubility |
title_full | Topography of Simulated Intestinal Equilibrium Solubility |
title_fullStr | Topography of Simulated Intestinal Equilibrium Solubility |
title_full_unstemmed | Topography of Simulated Intestinal Equilibrium Solubility |
title_short | Topography of Simulated Intestinal Equilibrium Solubility |
title_sort | topography of simulated intestinal equilibrium solubility |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505523/ https://www.ncbi.nlm.nih.gov/pubmed/30848917 http://dx.doi.org/10.1021/acs.molpharmaceut.8b01238 |
work_keys_str_mv | AT dunnclaire topographyofsimulatedintestinalequilibriumsolubility AT perrierjeremy topographyofsimulatedintestinalequilibriumsolubility AT khadraibrahim topographyofsimulatedintestinalequilibriumsolubility AT wilsoncliveg topographyofsimulatedintestinalequilibriumsolubility AT halbertgavinw topographyofsimulatedintestinalequilibriumsolubility |